Grassley Welcomes GlaxoSmithKline Disclosure of Payments to Hospitals, Professional Associations
M E M O R A N D U M
To: Reporters and Editors
Re: Grassley praises GlaxoSmithKline decision to publicly disclose grants
Da: August 22, 2008
Senator Chuck Grassley released the following statement in response to GlaxoSmithKline’s
decision to publicly disclose its grants to hospitals, professional associations, medical education
companies, and other groups.
Last fall, Grassley and Senator Herb Kohl introduced the Physician Payments Sunshine Act
in response to growing concerns about the lack of disclosure of the financial relationships between
pharmaceutical companies and individual physicians. The legislation has garnered support from the
medical community, including industry leaders, medical colleges, and professional societies.
Here is Grassley’s comment.
“GlaxoSmithKline is showing foresight by disclosing its third party payments and providing
greater transparency in the pharmaceutical industry. I appreciate the company’s promotion of
transparency and accountability. That benefits everyone, especially consumers.”
Next Article Previous Article